首頁 > 市場調查報告書 > 製藥

疼痛

市場調查報告書

商品編碼

1552625

北美合法大麻市場規模、佔有率和趨勢分析報告：按來源、按衍生物、按種植、按最終用途、按地區、按細分市場、預測，2024-2030 年

North America Legal Cannabis Market Size, Share & Trends Analysis Report By Source (Marijuana, Hemp), By Derivatives (CBD, THC), By Cultivation, By End Use (Medical, Recreational, Industrial), By Region, And Segment Forecasts, 2024 - 2030

出版日期: 2024年08月06日 | 出版商:

Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄圖表

北美合法大麻市場成長與趨勢

Grand View Research, Inc.最新報告顯示，到2030年，北美合法大麻市場規模預計將達到821.8億美元，2024年至2030年複合年成長率為11.9%。

因素包括大麻合法化、人們對大麻衍生產品的治療功效的認知提高以及大麻用於醫療和娛樂目的的增加。大麻衍生產品廣泛用於治療患有癌症、帕金森氏症、阿茲海默症和關節炎等慢性疾病的患者。

此外，越來越多的臨床試驗顯示利用大麻治療各種疾病的正面作用。例如，Sage Journal 於 2023 年 5 月發表的一項臨床研究發現，據報道，非吸入醫用大麻或大麻素對慢性疼痛患者的疼痛緩解、睡眠品質和身體功能的改善微乎其微。因此，這種積極的結果將增加該地區對大麻藥物的需求。

將人工智慧 (AI) 和機器人技術融入大麻種植中，透過提供先進的作物管理和預測能力來提高效率並標準化產量。該技術結合了環境條件和土壤品質等各種指標的資料分析，以預測潛在問題，最佳化耕作方法，並有效管理資源，降低成本和減少體力勞動。例如，加拿大的 PURPLEFARM 於 2024 年 6 月與人工智慧公司 Neatleaf 合作，利用 Neatleaf Spyder 系統來最佳化和自動化其大麻種植過程。

市場的主要企業包括 Canopy Growth Corporation 、 Charlotte's Web , Inc . 、 Aurora Cannabis 、 Tilray Brands 、 The Cronos Group 、 Jazz Pharmaceuticals , Inc . 、 Sundial Growers 和 Medipharm Labs 。這些公司正在採取重大策略措施來擴大其業務足跡和市場地位。例如，2022年11月，Charlotte's Web Inc.與加拿大大麻包裝商品公司Tilray建立了策略夥伴關係。這種合作關係使 Charlotte 能夠在加拿大生產和銷售 CBD 大麻萃取物。

北美合法大麻市場報告亮點

從來源來看，由於醫用大麻合法化程度不斷提高以及大麻產品的採用率不斷提高，預計大麻細分市場將在 2023 年佔據市場主導地位，並在預測期內成長最快。
從衍生性商品來看，由於 CBD 在各種醫療應用中的使用不斷增加，以及人們對 CBD 在治療各種醫療狀況方面的有效性的認知不斷增加，CBD 細分市場在 2023 年佔據了最大的市場佔有率。
以栽培領域來看，由於投資增加、技術進步和創新、有利的政府舉措和法律規範，室內領域在 2023 年佔據最大的市場佔有率。
按最終用途分類，受年輕人擴大採用大麻電子煙、大麻休閒用途增加以及預測期內最高成長率的推動，休閒細分市場將在 2023 年佔據市場主導地位，預計將快速成長。複合年成長率。
2023年，由於醫用大麻優惠的報銷政策以及消費者對大麻使用的積極態度，美國在北美合法大麻市場中佔據最大的市場佔有率。

定義和範圍
2023年及2030年種植市場佔有率分析
細分儀表板
北美合法大麻市場（按種植情況），2018-2030 年
室內栽培
- 2018-2030年室內種植市場估算與預測
溫室栽培
- 2018-2030年溫室栽培市場估價及預測
戶外栽培
- 2018-2030年戶外種植市場估計與預測

第 7 章：2018-2030 年北美合法大麻市場細分分析（按最終用途）（百萬美元）

定義和範圍
2023 年及 2030 年最終用途市場佔有率分析
細分儀表板
北美合法大麻市場（按最終用途），2018-2030 年
醫療用途
- 2018-2030年醫療市場收益估算與預測
- 癌症
- 慢性疼痛
- 憂鬱症和焦慮
- 關節炎
- 糖尿病
- 青光眼
- 偏頭痛
- 癲癇
- 多發性硬化症
- 愛滋病
- 肌萎縮側索硬化症
- 阿茲海默症
- 創傷後壓力症候群（PTSD）
- 帕金森氏症
- 妥瑞症
- 其他
休閒用途
- 2018-2030 年休閒用途市場收益估算與預測
工業用途
- 2018-2030年工業應用市場收益估算與預測

第 8 章：2018-2030 年北美合法大麻市場按地區、產品、材料和最終用途分析（百萬美元）

2023 年及 2030 年按地區分類的市場佔有率分析
區域市場儀表板
區域市場簡介
北美合法大麻市場佔有率（按地區，2023年和2030年）：
北美洲
- 北美合法大麻市場，2018-2030
- 美國
- 加拿大

第9章競爭格局

主要市場參與企業的最新趨勢和影響分析
公司分類
公司簡介
- Canopy Growth Corporation
- Charlotte's Web, Inc.
- Aurora Cannabis Inc.
- Tilray Brands
- The Cronos Group
- Jazz Pharmaceuticals, Inc.
- Sundial Growers
- Medipharm Labs
- NuLeaf Naturals, LLC
- Irwin Naturals

簡介目錄圖表

Product Code: GVR-4-68039-828-0

North America Legal Cannabis Market Growth & Trends:

The North America legal cannabis market size is expected to reach USD 82.18 billion by 2030, registering a CAGR of 11.9% from 2024 to 2030, according to a new report by Grand View Research, Inc. Factors such as legalization of cannabis, growing awareness about the therapeutic benefits of cannabis-based products, and rising use of cannabis for medical & recreational purposes. Cannabis-derived products are widely used for treating patients suffering from chronic conditions, such as cancer, Parkinson's disease, Alzheimer's disease, and arthritis.

Moreover, the rising number of clinical trials signifies the positive effects of utilizing cannabis for treating various medical conditions. For instance, a clinical study published by Sage Journal in May 2023 reported that non-inhaled medical cannabis or cannabinoids result in a very small to small improvement in pain relief, sleep quality, and physical functioning in patients suffering from chronic pain. Thus, such positive results increase the demand for cannabis-based medicines in this region.

Incorporating artificial intelligence (AI) and robotics into cannabis cultivation enhances efficiency and standardizes yields by offering advanced crop management and prediction capabilities. This technology reduces costs and the need for manual labor by incorporating data analysis from various indicators, such as environmental conditions and soil quality, forecasting potential problems, optimizing growing practices, and managing resources effectively. For instance, in June 2024, PURPLEFARM,a Canadian company, partnered with Neatleaf, an AI company, to optimize and automate its cannabis cultivation processes using the Neatleaf Spyder system.

Some of the key players in the market are Canopy Growth Corporation, Charlotte's Web, Inc., Aurora Cannabis, Tilray Brands, The Cronos Group, Jazz Pharmaceuticals, Inc., Sundial Growers, and Medipharm Labs. These companies adopt key strategic initiatives to expand their business footprint and market position. For instance, in November 2022, Charlotte's Web Inc. entered a strategic alliance with Tilray, a Canada-based cannabis packaged goods company. This alliance allows Charlotte to manufacture and distribute its CBD hemp extract offerings in Canada.

North America Legal Cannabis Market Report Highlights:

By source, the marijuana segment dominated the market in 2023 and is anticipated to witness the fastest growth over the forecast period owing to the growing adoption of marijuana products along with the increasing legalization of medical marijuana
By derivatives, the CBD segment held the largest market share in 2023, owing to the rising use of CBD for various medical applications and awareness regarding its effectiveness in treating various medical conditions
By cultivation, the indoor segment held the largest market share in 2023 due to rising investments, technological advancements & innovations, favorable government initiatives, and regulatory framework
By end use, the recreational segment dominated the market in 2023 and is anticipated to grow at the fastest CAGR over the forecast period due to the growing adoption of cannabis vape pens among youths and increased use of cannabis for recreational purposes
In 2023, the U.S. accounted for the largest market share in the North America legal cannabis market, owing to favorable reimbursement policies for medical cannabis and the positive attitude of consumers towards cannabis utilization

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
- 1.1.1. Segment scope
- 1.1.2. Regional scope
- 1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
1.4. Information or Data Analysis
- 1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.7. Research Assumptions
1.8. List of Secondary Sources
1.9. List of Primary Sources

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
- 2.2.1. Source outlook
- 2.2.2. Derivatives outlook
- 2.2.3. Cultivation outlook
- 2.2.4. End Use outlook
- 2.2.5. Regional outlook
2.3. Competitive Insights

Chapter 3. North America Legal Cannabis Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Ancillary market outlook
3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.2. Market restraint analysis
3.3. North America Legal Cannabis: Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.2. PESTLE Analysis
3.4. Regulatory Framework

Chapter 4. North America Legal Cannabis Market Segment Analysis, By Source, 2018 - 2030 (USD Million)

4.1. Definition and Scope
4.2. Product Market Share Analysis, 2023 & 2030
4.3. Segment Dashboard
4.4. North America Legal Cannabis market, by Source, 2018 to 2030
4.5. Marijuana
- 4.5.1. Marijuana market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.5.2. Flowers
  - 4.5.2.1. Flowers market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.5.3. Oil and Tinctures
  - 4.5.3.1. Oil and Tinctures market estimates and forecasts, 2018 to 2030 (USD Million)
4.6. Hemp
- 4.6.1. Hemp market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.6.2. Hemp CBD
  - 4.6.2.1. Hemp CBD market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.6.3. Industrial Hemp
  - 4.6.3.1. Industrial Hemp market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. North America Legal Cannabis Market Segment Analysis, By Derivatives, 2018 - 2030 (USD Million)

5.1. Definition and Scope
5.2. Derivatives Market Share Analysis, 2023 & 2030
5.3. Segment Dashboard
5.4. North America Legal Cannabis market, by Derivatives, 2018 to 2030
5.5. CBD
- 5.5.1. CBD market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. THC
- 5.6.1. THC market estimates and forecasts, 2018 to 2030 (USD Million)
5.7. Other derivatives
- 5.7.1. Other derivatives market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. North America Legal Cannabis Market Segment Analysis, By Cultivation, 2018 - 2030 (USD Million)

6.1. Definition and Scope
6.2. Cultivation Market Share Analysis, 2023 & 2030
6.3. Segment Dashboard
6.4. North America Legal Cannabis market, by Cultivation, 2018 to 2030
6.5. Indoor Cultivation
- 6.5.1. Indoor Cultivation market estimates and forecasts, 2018 to 2030 (USD Million)
6.6. Greenhouse Cultivation
- 6.6.1. Greenhouse Cultivation market estimates and forecasts, 2018 to 2030 (USD Million)
6.7. Outdoor Cultivation
- 6.7.1. Outdoor Cultivation market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. North America Legal Cannabis Market Segment Analysis, By End Use, 2018 - 2030 (USD Million)

7.1. Definition and Scope
7.2. End Use Market Share Analysis, 2023 & 2030
7.3. Segment Dashboard
7.4. Global North America Legal Cannabis Market, by End Use, 2018 to 2030
7.5. Medical Use
- 7.5.1. Medical Use Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.2. Cancer
  - 7.5.2.1. Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.3. Chronic Pain
  - 7.5.3.1. Chronic Pain Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.4. Depression and Anxiety
  - 7.5.4.1. Depression and Anxiety Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.5. Arthritis
  - 7.5.5.1. Arthritis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.6. Diabetes
  - 7.5.6.1. Diabetes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.7. Glaucoma
  - 7.5.7.1. Glaucoma Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.8. Migraine
  - 7.5.8.1. Migraine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.9. Epilepsy
  - 7.5.9.1. Epilepsy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.10. Multiple Sclerosis
  - 7.5.10.1. Multiple Sclerosis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.11. AIDS
  - 7.5.11.1. AIDS Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.12. Amyotrophic Lateral Sclerosis
  - 7.5.12.1. Amyotrophic Lateral Sclerosis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.13. Alzheimer's
  - 7.5.13.1. Alzheimer's Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.14. Post Traumatic Stress Disorder (PTSD)
  - 7.5.14.1. Post Traumatic Stress Disorder (PTSD) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.15. Parkinson's
  - 7.5.15.1. Parkinson's Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.16. Tourette's
  - 7.5.16.1. Tourette's Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.17. Others
  - 7.5.17.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Recreational Use
- 7.6.1. Recreational Use Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7. Industrial Use
- 7.7.1. Industrial Use Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. North America Legal Cannabis Market Segment Analysis, By Region, By Product, By Material, By End Use, 2018- 2030 (USD Million)

8.1. Regional Market Share Analysis, 2023 & 2030
8.2. Regional Market Dashboard
8.3. Regional Market Snapshot
8.4. North America Legal Cannabis Market Share by Region, 2023 & 2030:
8.5. North America
- 8.5.1. North America Legal Cannabis market, 2018 - 2030 (USD Million)
- 8.5.2. U.S.
  - 8.5.2.1. U.S. Legal Cannabis market, 2018 - 2030 (USD Million)
- 8.5.3. Canada
  - 8.5.3.1. Canada Legal Cannabis market, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Company Categorization
9.3. Company Profiles
- 9.3.1. Canopy Growth Corporation
  - 9.3.1.1. Company overview
  - 9.3.1.2. Financial performance
  - 9.3.1.3. Product benchmarking
  - 9.3.1.4. Strategic initiatives
- 9.3.2. Charlotte's Web, Inc.
  - 9.3.2.1. Company overview
  - 9.3.2.2. Financial performance
  - 9.3.2.3. Product benchmarking
  - 9.3.2.4. Strategic initiatives
- 9.3.3. Aurora Cannabis Inc.
  - 9.3.3.1. Company overview
  - 9.3.3.2. Financial performance
  - 9.3.3.3. Product benchmarking
  - 9.3.3.4. Strategic initiatives
- 9.3.4. Tilray Brands
  - 9.3.4.1. Company overview
  - 9.3.4.2. Financial performance
  - 9.3.4.3. Product benchmarking
  - 9.3.4.4. Strategic initiatives
- 9.3.5. The Cronos Group
  - 9.3.5.1. Company overview
  - 9.3.5.2. Financial performance
  - 9.3.5.3. Product benchmarking
  - 9.3.5.4. Strategic initiatives
- 9.3.6. Jazz Pharmaceuticals, Inc.
  - 9.3.6.1. Company overview
  - 9.3.6.2. Financial performance
  - 9.3.6.3. Product benchmarking
  - 9.3.6.4. Strategic initiatives
- 9.3.7. Sundial Growers
  - 9.3.7.1. Company overview
  - 9.3.7.2. Financial performance
  - 9.3.7.3. Product benchmarking
  - 9.3.7.4. Strategic initiatives
- 9.3.8. Medipharm Labs
  - 9.3.8.1. Company overview
  - 9.3.8.2. Financial performance
  - 9.3.8.3. Product benchmarking
  - 9.3.8.4. Strategic initiatives
- 9.3.9. NuLeaf Naturals, LLC
  - 9.3.9.1. Company overview
  - 9.3.9.2. Financial performance
  - 9.3.9.3. Product benchmarking
  - 9.3.9.4. Strategic initiatives
- 9.3.10. Irwin Naturals
  - 9.3.10.1. Company overview
  - 9.3.10.2. Financial performance
  - 9.3.10.3. Product benchmarking
  - 9.3.10.4. Strategic initiatives

簡介目錄圖表

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 North America legal cannabis market, by source, 2018 - 2030 (USD Million)
Table 4 North America legal cannabis market, by derivatives, 2018 - 2030 (USD Million)
Table 5 North America legal cannabis market, by end use, 2018 - 2030 (USD Million)
Table 6 North America North America legal cannabis market, by cultivation, 2018 - 2030 (USD Million)
Table 7 North America North America legal cannabis market, by region, 2018 - 2030 (USD Million)
Table 8 U.S legal cannabis market, by source, 2018 - 2030 (USD Million)
Table 9 U.S legal cannabis market, by derivatives, 2018 - 2030 (USD Million)
Table 10 U.S legal cannabis market, by cultivation, 2018 - 2030 (USD Million)
Table 11 U.S legal cannabis market, by end use, 2018 - 2030 (USD Million)
Table 12 Canada legal cannabis market, by source, 2018 - 2030 (USD Million)
Table 13 Canada legal cannabis market, by derivatives, 2018 - 2030 (USD Million)
Table 14 Canada legal cannabis market, by cultivation, 2018 - 2030 (USD Million)
Table 15 Canada legal cannabis market, by end use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 North America legal cannabis market: outlook
Fig. 9 North America legal cannabis competitive insights
Fig. 10 Ancillary market outlook
Fig. 11 North America legal cannabis market driver impact
Fig. 12 North America legal cannabis market restraint impact
Fig. 13 Porter's Analysis
Fig. 14 PESTLE Analysis
Fig. 15 North America legal cannabis market: Source movement analysis
Fig. 16 North America legal cannabis market: Source outlook and key takeaways
Fig. 17 Marijuana market estimates and forecast, 2018 - 2030
Fig. 18 Flowers market estimates and forecast, 2018 - 2030
Fig. 19 Oil and Tinctures market estimates and forecast, 2018 - 2030
Fig. 20 Hemp market estimates and forecast, 2018 - 2030
Fig. 21 Hemp CBD market estimates and forecast, 2018 - 2030
Fig. 22 Industrial Hemp market estimates and forecast, 2018 - 2030
Fig. 23 North America legal cannabis market: Derivatives movement analysis
Fig. 24 North America legal cannabis market: Derivatives outlook and key takeaways
Fig. 25 CBD market estimates and forecasts, 2018 - 2030
Fig. 26 THC market estimates and forecasts, 2018 - 2030
Fig. 27 Other derivatives market estimates and forecasts, 2018 - 2030
Fig. 28 North America legal cannabis market: Cultivation movement analysis
Fig. 29 North America legal cannabis market: Cultivation outlook and key takeaways
Fig. 30 Indoor Cultivation market estimates and forecasts, 2018 - 2030
Fig. 31 Greenhouse Cultivation market estimates and forecasts, 2018 - 2030
Fig. 32 Outdoor Cultivation market estimates and forecasts, 2018 - 2030
Fig. 33 North America legal cannabis market: End Use movement analysis
Fig. 34 North America legal cannabis market: End Use outlook and key takeaways
Fig. 35 Medical Use market estimates and forecasts, 2018 - 2030
Fig. 36 Chronic Pain market estimates and forecasts, 2018 - 2030
Fig. 37 Depression and Anxiety market estimates and forecasts, 2018 - 2030
Fig. 38 Post-Traumatic Stress Disorder (PTSD) market estimates and forecasts, 2018 - 2030
Fig. 39 Arthritis market estimates and forecasts, 2018 - 2030
Fig. 40 Migraines market estimates and forecasts, 2018 - 2030
Fig. 41 Cancer market estimates and forecasts, 2018 - 2030
Fig. 42 Epilepsy market estimates and forecasts, 2018 - 2030
Fig. 43 Alzheimer's market estimates and forecasts, 2018 - 2030
Fig. 44 Multiple Sclerosis market estimates and forecasts, 2018 - 2030
Fig. 45 Diabetes market estimates and forecasts, 2018 - 2030
Fig. 46 Tourette's market estimates and forecasts, 2018 - 2030
Fig. 47 Parkinson's market estimates and forecasts, 2018 - 2030
Fig. 48 AIDS market estimates and forecasts, 2018 - 2030
Fig. 49 Glaucoma market estimates and forecasts, 2018 - 2030
Fig. 50 Amyotrophic Lateral Sclerosis market estimates and forecasts, 2018 - 2030
Fig. 51 Hospitals market estimates and forecasts, 2018 - 2030
Fig. 52 Others market estimates and forecasts, 2018 - 2030
Fig. 53 Recreational Use market estimates and forecasts, 2018 - 2030
Fig. 54 Industrial Use market estimates and forecasts, 2018 - 2030
Fig. 55 North America legal cannabis market: Regional movement analysis
Fig. 56 North America legal cannabis market: Regional outlook and key takeaways
Fig. 57 North America North America legal cannabis market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 Key country dynamics
Fig. 59 U.S. legal cannabis market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 Key country dynamics
Fig. 61 Canada legal cannabis market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 62 Key country dynamics
Fig. 63 Key company categorization
Fig. 64 Heat map analysis, 2022 - 2023